Induction of mutual stabilization and retardation of tumor growth by coexpression of plakoglobin and E-cadherin in mouse skin spindle carcinoma cells

Molecular Carcinogenesis

Volumn 21, Issue 4, 1998, Pages 273-287

  Lozano, Encarnacion ^a   Cano, Amparo ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CSIC   (Spain)

Author keywords

Cell cell adhesion; E cadherin; Plakoglobin; Skin carcinogenesis; Tumorigenesis

Indexed keywords

PLAKOGLOBIN; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM HOMEOSTASIS; CANCER INHIBITION; CARCINOGENESIS; CELL ADHESION; CYTOSKELETON; DROSOPHILA; ENZYME ACTIVITY; FIBROBLAST; GENE EXPRESSION; GROWTH RETARDATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN CARCINOMA; TUMOR GROWTH;

ANIMALS; CADHERINS; CALCIUM; CARCINOMA; CELL ADHESION; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; CYTOSKELETAL PROTEINS; DESMOPLAKINS; DETERGENTS; DISEASE PROGRESSION; DNA, COMPLEMENTARY; FIBROBLASTS; GAMMA CATENIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HALF-LIFE; HUMANS; KERATINOCYTES; MACROMOLECULAR SUBSTANCES; MALE; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PHENOTYPE; SKIN NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA; MURINAE;

EID: 0031959549     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199804)21:4<273::AID-MC6>3.0.CO;2-L     Document Type: Article

References (67)

1. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251:1451-1455, 1991.
2. Takeichi M. Cadherins in cancer: Implications for invasion and metastasis. Curr Opin Cell Biol 5:806-811, 1993.
3. Birchmeier W, Behrens J. Cadherin expression in carcinomas: Role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1198:11-26, 1994.
4. Nose A, Tsuji K, Takeichi M. Localization of specific determining sites in cadherin cell adhesion molecules. Cell 61:147-155, 1990.
5. Ozawa M, Kemler R. Molecular organization of the uvomorulin-catenin complex. J Cell Biol 116:989-996, 1992.
6. Cowin P, Burke B. Cytoskeleton-membrane interactions. Curr Opin Cell Biol 8:56-65, 1996.
7. Reynolds AB, Daniel J, McCrea PD, Wheelock MJ, Wu J, Zhang Z. Identification of a new catenin: The tyrosine kinase substrate p120cas associates with E-cadherin complexes. Mol Cell Biol 14:8333-8342, 1994.
8. Nagafuchi A, Takeichi M, Tsukita S. The 102 kd cadherin-associated protein: Similarity to vinculin and posttranscriptional regulation of expression. Cell 65:849-857, 1991.
9. Herrenknecht K, Ozawa M, Eckerskon C, Lottspeich F, Lenter M, Kemler R. The uvomorulin-anchorage protein α-catenin is a vinculin homologue. Proc Natl Acad Sci USA 88:9156-9160, 1991.
10. Peifer M, McCrea P, Green KJ, Wieschaus E, Gumbiner B. The vertebrate adhesive junction proteins β-catenin and plakoglobin and the Drosophila segment polarity gene armadillo form a multigene family with similar properties. J Cell Biol 118:681-691, 1992.
11. Peifer M, Berg S, Reynolds AB. A repeating amino acid motif shared by proteins with diverse cellular roles. Cell 76:789-791, 1994.
12. v-src, is related to cadherin-binding factors β-catenin, plakoglobin and armadillo. Oncogene 7:2439-2445, 1992.
13. Shimoyama Y, Nagafuchi A, Fujita S, et al. Cadherin dysfunction in a human cancer cell line: Possible involvement of loss of α-catenin expression in reduced cell-cell adhesiveness. Cancer Res 52:5770-5774, 1992.
14. Oda T, Kanai Y, Shimoyama Y, Nagafuchi A, Tsukita S, Hirohashi S. Cloning of the human α-catenin cDNA and its aberrant mRNA in a human cancer cell line. Biochem Biophys Res Commun 193:897-904, 1993.
15. Kawanishi J, Kato J, Sasaki K, Fujii S, Watanabe N, Niitsu Y. Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the β-catenin gene in a human cancer cell line, HSC-39. Mol Cell Biol 15:1175-1181, 1995.
16. OyamaT, Kanai Y, Ochiai A, et al. A truncated β-catenin disrupts the interaction between E-cadherin and α-catenin: A cause of loss of intercellular adhesiveness in human cancer cell lines. Cancer Res 54:6282-6287, 1994.
17. Matsuyoshi N, Hamaguchi M, Taniguchi S, Nagafuchi A, Tsukita S, Takeichi M. Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts. J Cell Biol 118:703-714, 1992.
18. Behrens J, Vakaet L, Friis R, et al. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/β-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol 120:757-766, 1993.
19. v-src causes tyrosine phosphorylation and inactivation of the N-cadherin-catenin cell adhesion system. EMBO J 12:307-314, 1993.
20. Watabe M, Nagafuchi A, Tsukita S, Takeichi M. Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma cell line. J Cell Biol 127:247-256, 1994.
21. Shibamoto S, Hayakawa M, Takeuchi K, et al. Tyrosine phosphorylation of β-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhes Commun 1:295-305, 1994.
22. Hoschuetzky H, Aberle H, Kemler R. β-catenin mediates the interaction of the E-cadherin-catenin complex with epidermal growth factor receptor. J Cell Biol 127:1375-1380, 1994.
23. Frixen UH, Behrens J, Sachs M, et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113:173-185, 1991.
24. Navarro P, Gómez M, Pizarro A, Gamallo C, Quintanilla M, Cano A. A role for the E-cadherin cell-cell adhesion molecule in tumor progression of mouse epidermal carcinogenesis. J Cell Biol 115:517-533, 1991.
25. Vlemynckx K, Vakaet L Jr, Mareel MM, Fiers W, Van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 66:107-119, 1991.
26. Hirano S, Kimoto N, Shimoyama Y, Hirohashi S, Takeichi M. Identification of a neural α-catenin as a key regulator of cadherin function and multicellular organization. Cell 70:293-301, 1992.
27. Näthke IS, Hinck L, Swedlow JR, Papkoff J, Nelson WJ. Defining interactions and distributions of cadherin and catenin complexes in polarized epithelial cells. J Cell Biol 125:1341-1352, 1994.
28. 2+-dependent cell-cell adhesion. FEBS Lett 355:195-200, 1994.
29. Hülsken J, Birchmeier W, Behrens J. E-cadherin and APC compete for the interaction of β-catenin and the cytoskeleton. J Cell Biol 127:2061-2069, 1994.
30. Sacco PA, McGranahan TM, Wheelock MJ, Johnson KR. Identification of plakoglobin domains required for association with N-cadherin and α-catenin. J Biol Chem 270:20201-20206, 1995.
31. Nagafuchi A, Ishihara S, Tsukita S. The roles of catenins in the cadherin-mediated cell adhesion: Functional analysis of E-cadherin-α-catenin fusion molecules. J Cell Biol 127:235-245, 1994.
32. Rimm DL, Koslov ER, Kebriaei P, Cianci CD, Morrow JS. α1(E)-Catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex. Proc Natl Acad Sci USA 92:8813-8817, 1995.
33. Knudsen KA, Peralta Soler A, Johnson KR, Wheelock MJ. Interaction of α-actinin with the E-cadherin/catenin cell-cell adhesion complex via α-catenin. J Cell Biol 130:67-77, 1995.
34. Gumbiner BM. Signal transduction by β-catenin. Curr Opin Cell Biol 7:634-640, 1995.
35. Eaton S, Cohen S. Wnt signal transduction: More than a way to skin a (β-) cat? Trends Cell Biol 6:287-290, 1996.
36. Behrens J, von Kries JP, Kühl M, et al. Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382:638-642, 1996.
37. Munemitsu S, Albert I, Souza B, Rubinfeld B, Polakis P. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci USA 92:3046-3050, 1995.
38. Morin PJ, Sparks AB, Korinek V, et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275:1787-1790, 1997.
39. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P. Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 275:1790-1792, 1997.
40. Cowin P, Kapprell H-P, Franke WW, Tamkum J, Hynes RO. Plakoglobin: A protein common to different kinds of intercellular adhering junctions. Cell 46:1063-1073, 1986.
41. Troyanovsky SM, Troyanovsky RB, Eshkind LG, Krutovskikh VA, Leube RE, Franke WW. Identification of the plakoglobin-binding domain in desmoglein and its role in plaque assembly and intermediate filament anchorage. J Cell Biol 127:151-160, 1994.
42. Wahl JK, Sacco PA, McGranahan-Sadler TM, Sauppé LM, Wheelock MJ, Johnson KR. Plakoglobin domains that define its association with the desmosomal cadherins and the classical cadherins: Identification of unique and shared domains. J Cell Sci 109:1143-1154, 1996.
43. Simcha I, Geiger B, Yehuda-Levenberg S, Salomon D, Ben-Ze'ev A. Suppression of tumorigenicity by plakoglobin: An augmenting effect of N-cadherin. J Cell Biol 133:199-209, 1996.
44. Navarro P, Lozano E, Cano A. Expression of E- or P-cadherin is not sufficient to modify the morphology and the tumorigenic behavior of murine spindle carcinoma cells. Possible involvement of plakoglobin. J Cell Sci 105:923-934, 1993.
45. Sommers CL, Gelmann EP, Kemler R, Cowin P, Byers SW. Alterations in β-catenin phosphorylation and plakoglobin expression in human breast cancer cells. Cancer Res 54:3544-3552, 1994.
46. Bremner R, Balmain A. Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7. Cell 61:407-417, 1990.
47. Kulesz-Martin M, Kilkenny AE, Holbroock KA, Digernes V, Yuspa SH. Properties of carcinogen altered mouse epidermal cells resistant to calcium induced terminal differentiation. Carcinogenesis 4:1367-1377, 1983.
48. Fusenig NE, Brietkreuzt D, Dzrlieva RT, et al. Epidermal cell differentiation and malignant transformation in culture. Cancer Forum 6:209-240, 1982.
49. Franke WW, Goldschmidt MD, Zimbelmann R, Mueller HM, Schiller DL, Cowin P. Molecular cloning and amino acid sequence of human plakoglobin, the common junctional plaque protein. Proc Natl Acad Sci USA 86:4027-4031, 1989.
50. Braga VMM, Hodivala KJ, Watt FM. Calcium-induced changes in distribution and solubility of cadherins, integrins and their associated cytoplasmic proteins in human keratinocytes. Cell Adhes Commun 3:201-215, 1995.
51. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685, 1970.
52. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987.
53. Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activities. Anal Biochem 137:266-267, 1983.
54. Gómez M, Navarro P, Quintanilla M, Cano A. Expression of α6β4 integrin increases during malignant conversion of mouse epidermal keratinocytes: Association of β4 subunit to the cytokeratin fraction. Exp Cell Res 201:250-261, 1992.
55. Inki P, Gómez M, Quintanilla M, Cano A, Jalkanen M. Expression of syndecan in transformed mouse keratinocytes. Lab Invest 62:225-233, 1992.
56. Díaz-Guerra M, Haddow S, Bauluz C, et al. Expression of simple epithelial cytokeratins in mouse epidermal keratinocytes harbouring Harvey ras gene alterations. Cancer Res 52:680-687, 1992.
57. Lampugnani MG, Corada M, Caveda L, et al. The molecular organization of endothelial cell to cell junctions: Differential association of plakoglobin, beta-catenin and alpha-catenin with vascular endothelial cadherin (VE-cadherin). J Cell Biol 129:203-217, 1995.
58. Islam S, Carey TE, Wolf GT, Wheelock MJ, Johnson KR. Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J Cell Biol 135:1643-1654, 1996.
59. Stoler AB, Stenback F, Balmain A. The conversion of mouse skin squamous cell carcinomas to spindle cell carcinomas is a recessive event. J Cell Biol 122:1103-1117, 1993.
60. Buchmann A, Ruggeri B, Klein-Szanto AJ, Balmain A. Progression of squamous carcinoma cells to spindle carcinomas of mouse skin is associated with an imbalance of Ha-ras alleles on chromosome 7. Cancer Res 51:4097-4101, 1991.
61. Burns PA, Kemp CJ, Gannon JV, Lane DP, Bremner R, Balmain A. Loss of heterozygosity and mutational alterations of the p53 gene in skin tumors of interspecific hybrid mice. Oncogene 6:2363-2369, 1991.
62. Caulín C, Scholl FG, Frontelo P, Gamallo C, Quintanilla M. Chronic exposure of cultured transformed mouse epidermal cells to transforming growth factor-β1 induces an epithelial-mesenchymal transdifferentiation and a spindle tumoral phenotype. Cell Growth Differ 6:1027-1035, 1995.
63. Cui W, Fowlis DJ, Bryson S, et al.TGFβ1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86:531-542, 1996.
64. Kowalczyk AP, Palka HL, Luu HH, et al. Posttranslational regulation of plakoglobin expression. Influence of the desmosomal cadherins on plakoglobin metabolic stability. J Biol Chem 269:31214-31223, 1994.
65. McNeill H, Ryan TA, Smith SJ, Nelson WJ. Spatial and temporal dissection of immediate and early events following cadherin-mediated epithelial cell adhesion. J Cell Biol 120:1217-1226, 1993.
66. Gómez M, Navarro P, Cano A. Cell adhesion and tumor progression in mouse skin carcinogenesis: Increased synthesis and organization of fibronectin is associated with the undifferentiated spindle phenotype. Invasion Metastasis 14:17-26, 1994.
67. Gómez M, Cano A. Expression of β1 integrin receptors in transformed mouse epidermal keratinocytes: Upregulation of α5β1 in spindle carcinoma cells. Mol Carcinog 12:153-165, 1995.